EUVIMEDEUVIMED entdecken
Crossref

Mitoxantrone Combined with Engineered TRAIL‐Nanovesicles for Enhanced Cancer Immunotherapy Via Converting Apoptosis into Pyroptosis

Yi Wang, Boning Niu, Yinmei Tian, Hongbing Lan, Zhanhao Zhou, Yang Li, Siyu Zhao, Yu Zhang, Conglian Yang, Li Kong, Zhiping Zhang iD

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202401723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Yi Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, 430030, China. Hauptthemen laut MEDLINE: Pyroptosis, TNF-Related Apoptosis-Inducing Ligand, Immunotherapy, Mitoxantrone. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Program for HUST Academic Frontier Youth Team, Wuhan Science and Technology Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyroptosis, a highly inflammatory form of programmed cell death, has emerged as a promising target for cancer immunotherapy. However, in the context of pyroptosis execution, while both caspase‐3 and GSDME are essential, it is noteworthy that GSDME is frequently under‐expressed in cold tumors. To overcome this limitation, engineered cellular nanovesicles (NVs) presenting TRAIL on their membranes (NV TRAIL ) are developed to trigger the upregulation of cleaved caspase‐3. When strategically combined with the chemotherapeutic agent mitoxantrone (MTO), known for its ability to enhance GSDME expression, MTO@NV TRAIL can convert cancer cells from apoptosis into pyroptosis, inhibit the tumor growth and metastasis successfully in primary tumor. The microparticles released by pyroptotic tumor cells also exhibited certain cytotoxicity against other tumor cells. In addition, tumor cells exposed to the combination treatment of MTO@NV TRAIL in vitro have also demonstrated potential utility as a novel form of vaccine for cancer immunotherapy. Flow analysis of the tumor microenvironment and draining lymph nodes reveals an increased proportion of matured dendritic cells and activation of T cells. In summary, the research provided a reference and alternative approach to induce cancer pyroptosis for clinical antitumor therapy based on engineered cellular nanovesicles and chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisTNF-Related Apoptosis-Inducing LigandImmunotherapyMitoxantroneAnimalsHumansMiceCell Line, TumorApoptosisNeoplasmsTumor MicroenvironmentNanoparticlesFemaleMice, Inbred BALB CCaspase 3

Stichwörter der Autor:innen

TRAILcold tumorimmunotherapynanovesiclespyroptosis

Substanzen

TNF-Related Apoptosis-Inducing LigandMitoxantroneCaspase 3

Autor:innen und Institutionen

  • Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Liyuan Hospital, Huazhong University of Science and Technology, Wuhan, 430077, China.
  • National Engineering Research Center for Nanomedicine, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Hubei Engineering Research Centre for Novel Drug Delivery System, Huazhong University of Science and Technology, Wuhan, 430030, China.

ORCID-Profile: Zhiping Zhang

Förderung

  • National Natural Science Foundation of China
  • Program for HUST Academic Frontier Youth Team
  • Wuhan Science and Technology Plan

Zitieren

APA

Wang, Y., Niu, B., Tian, Y., Lan, H., Zhou, Z., Li, Y., Zhao, S., Zhang, Y., Yang, C., Kong, L., & Zhang, Z. (2024). Mitoxantrone Combined with Engineered TRAIL‐Nanovesicles for Enhanced Cancer Immunotherapy Via Converting Apoptosis into Pyroptosis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401723

Vancouver

Wang Y, Niu B, Tian Y, Lan H, Zhou Z, Li Y, et al. Mitoxantrone Combined with Engineered TRAIL‐Nanovesicles for Enhanced Cancer Immunotherapy Via Converting Apoptosis into Pyroptosis. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401723

BibTeX
@article{Wang2024,
  author = {Wang, Yi and Niu, Boning and Tian, Yinmei and Lan, Hongbing and Zhou, Zhanhao and Li, Yang and Zhao, Siyu and Zhang, Yu and Yang, Conglian and Kong, Li and Zhang, Zhiping},
  title = {Mitoxantrone Combined with Engineered TRAIL‐Nanovesicles for Enhanced Cancer Immunotherapy Via Converting Apoptosis into Pyroptosis},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202401723}
}
Kostenlos starten →